Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000049.xml
Download PDF
Clin Colon Rectal Surg 2023; 36(01): 063-073
DOI: 10.1055/s-0042-1758770
DOI: 10.1055/s-0042-1758770
Review Article
Anastomotic Considerations in Crohn's Disease
Abstract
A number of factors should be considered when performing an intestinal anastomosis in the setting of surgery for Crohn's disease. Preoperative risk factors, such as malnutrition, abdominal sepsis, and immunosuppressive medications, may increase the risk of postoperative anastomotic complications and alter surgical decision-making. The anatomical configuration and technique of constructing the anastomosis may have an impact on postoperative function and risk of recurrence, particularly in the setting of ileocolic resection, where the Kono-S anastomosis has gained popularity in recent years. There may be circumstances in which it may be more appropriate to perform an ostomy either without an anastomosis or to temporarily divert an anastomosis when the risk of anastomotic complications is felt to be high. In the setting of total abdominal colectomy or proctocolectomy for Crohn's colitis, restorative procedures may appropriate in lieu of a permanent stoma in certain scenarios.
Publication History
Article published online:
09 December 2022
© 2022. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 2000; 231 (01) 38-45
- 2 Vester-Andersen MK, Prosberg MV, Jess T. et al. Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy. Am J Gastroenterol 2014; 109 (05) 705-714
- 3 Steele S, Hull TL, Hyman N, Maykel JA, Read TE, Whitlow CB. American Society of Colon and Rectal Surgeons. The ASCRS Textbook of Colon and Rectal Surgery. 4th ed.. New York: Springer; 2022
- 4 Cao Q, Huang YH, Jiang M, Dai C. The prevalence and risk factors of psychological disorders, malnutrition and quality of life in IBD patients. Scand J Gastroenterol 2019; 54 (12) 1458-1466
- 5 Swaminath A, Feathers A, Ananthakrishnan AN, Falzon L, Li Ferry S. Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease. Aliment Pharmacol Ther 2017; 46 (07) 645-656
- 6 Yamamoto T, Shiraki M. Efficacy of enteral nutrition during infliximab maintenance therapy in patients with Crohn's disease. Dig Dis Sci 2013; 58 (06) 1802-1803
- 7 Mijac DD, Janković GL, Jorga J, Krstić MN. Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition and methods for routine nutritional assessment. Eur J Intern Med 2010; 21 (04) 315-319
- 8 Valentini L, Schulzke JD. Mundane, yet challenging: the assessment of malnutrition in inflammatory bowel disease. Eur J Intern Med 2011; 22 (01) 13-15
- 9
Yamamoto T,
Allan RN,
Keighley MR.
Risk factors for intra-abdominal sepsis after surgery in Crohn's disease. Dis Colon
Rectum 2000; 43 (08) 1141-1145
MissingFormLabel
- 10 Myrelid P, Olaison G, Sjödahl R, Nyström PO, Almer S, Andersson P. Thiopurine therapy is associated with postoperative intra-abdominal septic complications in abdominal surgery for Crohn's disease. Dis Colon Rectum 2009; 52 (08) 1387-1394
- 11 Post S, Betzler M, von Ditfurth B, Schürmann G, Küppers P, Herfarth C. Risks of intestinal anastomoses in Crohn's disease. Ann Surg 1991; 213 (01) 37-42
- 12 Shental O, Tulchinsky H, Greenberg R, Klausner JM, Avital S. Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for Crohn's disease. Dis Colon Rectum 2012; 55 (11) 1125-1130
- 13 Tay GS, Binion DG, Eastwood D, Otterson MF. Multivariate analysis suggests improved perioperative outcome in Crohn's disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty. Surgery 2003; 134 (04) 565-572 , discussion 572–573
- 14 Reindl W, Thomann AK, Galata C, Kienle P. Reducing perioperative risks of surgery in Crohn's disease. Visc Med 2019; 35 (06) 348-354
- 15 Ferrandis C, Souche R, Bardol T. et al. Personalized pre-habilitation reduces anastomotic complications compared to up front surgery before ileocolic resection in high-risk patients with Crohn's disease: a single center retrospective study. Int J Surg 2022; 105: 106815
- 16 Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 1999; 134 (01) 36-42
- 17 Tzivanakis A, Singh JC, Guy RJ, Travis SP, Mortensen NJ, George BD. Influence of risk factors on the safety of ileocolic anastomosis in Crohn's disease surgery. Dis Colon Rectum 2012; 55 (05) 558-562
- 18 Alves A, Panis Y, Bouhnik Y, Pocard M, Vicaut E, Valleur P. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum 2007; 50 (03) 331-336
- 19 Morar PS, Hodgkinson JD, Thalayasingam S. et al. Determining predictors for intra-abdominal septic complications following ileocolonic resection for Crohn's disease-considerations in pre-operative and peri-operative optimisation techniques to improve outcome. J Crohn's Colitis 2015; 9 (06) 483-491
- 20 Kanazawa A, Yamana T, Okamoto K, Sahara R. Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn's disease. Dis Colon Rectum 2012; 55 (09) 957-962
- 21 Iesalnieks I, Kilger A, Glass H. et al. Intraabdominal septic complications following bowel resection for Crohn's disease: detrimental influence on long-term outcome. Int J Colorectal Dis 2008; 23 (12) 1167-1174
- 22 Crowell KT, Messaris E. Risk factors and implications of anastomotic complications after surgery for Crohn's disease. World J Gastrointest Surg 2015; 7 (10) 237-242
- 23 Heimann TM, Greenstein AJ, Mechanic L, Aufses Jr AH. Early complications following surgical treatment for Crohn's disease. Ann Surg 1985; 201 (04) 494-498
- 24 Resegotti A, Astegiano M, Farina EC. et al. Side-to-side stapled anastomosis strongly reduces anastomotic leak rates in Crohn's disease surgery. Dis Colon Rectum 2005; 48 (03) 464-468
- 25 Huang W, Tang Y, Nong L, Sun Y. Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: a meta-analysis of observational studies. J Crohn's Colitis 2015; 9 (03) 293-301
- 26 Lavorini E, Allaix ME, Ammirati CA, Astegiano M, Morino M, Resegotti A. Late is too late? Surgical timing and postoperative complications after primary ileocolic resection for Crohn's disease. Int J Colorectal Dis 2022; 37 (04) 843-848
- 27 Aberra FN, Lewis JD, Hass D, Rombeau JL, Osborne B, Lichtenstein GR. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 2003; 125 (02) 320-327
- 28 Kunitake H, Hodin R, Shellito PC, Sands BE, Korzenik J, Bordeianou L. Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg 2008; 12 (10) 1730-1736 , discussion 1736–1737
- 29 Colombel JF, Loftus Jr EV, Tremaine WJ. et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004; 99 (05) 878-883
- 30 Kasparek MS, Bruckmeier A, Beigel F. et al. Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery. Inflamm Bowel Dis 2012; 18 (07) 1207-1213
- 31 Kjeldsen J, Nielsen J, Larsen MD, Qvist N, Nørgård BM. Postoperative use of anti-TNF-α agents in patients with Crohn's disease and risk of reoperation-a nationwide cohort study. Inflamm Bowel Dis 2016; 22 (03) 599-606
- 32 Krane MK, Allaix ME, Zoccali M. et al. Preoperative infliximab therapy does not increase morbidity and mortality after laparoscopic resection for inflammatory bowel disease. Dis Colon Rectum 2013; 56 (04) 449-457
- 33 Canedo J, Lee SH, Pinto R, Murad-Regadas S, Rosen L, Wexner SD. Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates?. Colorectal Dis 2011; 13 (11) 1294-1298
- 34 Cohen BL, Fleshner P, Kane SV. et al. Prospective cohort study to investigate the safety of preoperative tumor necrosis factor inhibitor exposure in patients with inflammatory bowel disease undergoing intra-abdominal surgery. Gastroenterology 2022; 163 (01) 204-221
- 35 Law CCY, Narula A, Lightner AL, McKenna NP, Colombel JF, Narula N. Systematic review and meta-analysis: preoperative vedolizumab treatment and postoperative complications in patients with inflammatory bowel disease. J Crohn's Colitis 2018; 12 (05) 538-545
- 36 Yung DE, Horesh N, Lightner AL. et al. Systematic review and meta-analysis: vedolizumab and postoperative complications in inflammatory bowel disease. Inflamm Bowel Dis 2018; 24 (11) 2327-2338
- 37 Moosvi Z, Duong JT, Bechtold ML, Nguyen DL. Systematic review and meta-analysis: preoperative vedolizumab and postoperative complications in patients with IBD. South Med J 2021; 114 (02) 98-105
- 38 Lightner AL, McKenna NP, Tse CS. et al. Postoperative outcomes in Ustekinumab-treated patients undergoing abdominal operations for Crohn's disease. J Crohn's Colitis 2018; 12 (04) 402-407
- 39 Novello M, Stocchi L, Holubar S. et al. Surgical outcomes of patients treated with Ustekinumab vs. vedolizumab in inflammatory bowel disease: a matched case analysis. Int J Colorectal Dis 2019; 34 (03) 451-457
- 40
Lightner AL,
Vogel JD,
Carmichael JC.
et al.
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for
the surgical management of Crohn's disease. Dis Colon Rectum 2020; 63 (08) 1028-1052
MissingFormLabel
- 41 Simillis C, Purkayastha S, Yamamoto T, Strong SA, Darzi AW, Tekkis PP. A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn's disease. Dis Colon Rectum 2007; 50 (10) 1674-1687
- 42 He X, Chen Z, Huang J. et al. Stapled side-to-side anastomosis might be better than handsewn end-to-end anastomosis in ileocolic resection for Crohn's disease: a meta-analysis. Dig Dis Sci 2014; 59 (07) 1544-1551
- 43 Guo Z, Li Y, Zhu W, Gong J, Li N, Li J. Comparing outcomes between side-to-side anastomosis and other anastomotic configurations after intestinal resection for patients with Crohn's disease: a meta-analysis. World J Surg 2013; 37 (04) 893-901
- 44 Celentano V, Pellino G, Spinelli A. et al; SICCR Current status of Crohn's disease surgery collaborative, on behalf of the Italian Society of Colorectal Surgery SICCR. Anastomosis configuration and technique following ileocaecal resection for Crohn's disease: a multicentre study. Updates Surg 2021; 73 (01) 149-156
- 45 Gajendran M, Bauer AJ, Buchholz BM. et al. Ileocecal anastomosis type significantly influences long-term functional status, quality of life, and healthcare utilization in postoperative Crohn's disease patients independent of inflammation recurrence. Am J Gastroenterol 2018; 113 (04) 576-583
- 46 Muñoz-Juárez M, Yamamoto T, Wolff BG, Keighley MR. Wide-lumen stapled anastomosis vs. conventional end-to-end anastomosis in the treatment of Crohn's disease. Dis Colon Rectum 2001; 44 (01) 20-25 , discussion 25–26
- 47 Scarpa M, Ruffolo C, Bertin E. et al. Surgical predictors of recurrence of Crohn's disease after ileocolonic resection. Int J Colorectal Dis 2007; 22 (09) 1061-1069
- 48 Kono T, Ashida T, Ebisawa Y. et al. A new antimesenteric functional end-to-end handsewn anastomosis: surgical prevention of anastomotic recurrence in Crohn's disease. Dis Colon Rectum 2011; 54 (05) 586-592
- 49 Kono T, Fichera A, Maeda K. et al. Kono-S anastomosis for surgical prophylaxis of anastomotic recurrence in Crohn's disease: an international multicenter study. J Gastrointest Surg 2016; 20 (04) 783-790
- 50 Shimada N, Ohge H, Kono T. et al. Surgical recurrence at anastomotic site after bowel resection in Crohn's disease: comparison of Kono-S and end-to-end anastomosis. J Gastrointest Surg 2019; 23 (02) 312-319
- 51 Luglio G, Rispo A, Imperatore N. et al. Surgical prevention of anastomotic recurrence by excluding mesentery in Crohn's disease: the SuPREMe-CD Study – a randomized clinical trial. Ann Surg 2020; 272 (02) 210-217
- 52 Alshantti A, Hind D, Hancock L, Brown SR. The role of Kono-S anastomosis and mesenteric resection in reducing recurrence after surgery for Crohn's disease: a systematic review. Colorectal Dis 2021; 23 (01) 7-17
- 53 Carr ND, Pullan BR, Schofield PF. Microvascular studies in non-specific inflammatory bowel disease. Gut 1986; 27 (05) 542-549
- 54 Angerson WJ, Allison MC, Baxter JN, Russell RI. Neoterminal ileal blood flow after ileocolonic resection for Crohn's disease. Gut 1993; 34 (11) 1531-1534
- 55 Coffey CJ, Kiernan MG, Sahebally SM. et al. Inclusion of the mesentery in ileocolic resection for Crohn's disease is associated with reduced surgical recurrence. J Crohn's Colitis 2018; 12 (10) 1139-1150
- 56 Baker WN. Ileo-rectal anastomosis for Crohn's disease of the colon. Gut 1971; 12 (06) 427-431
- 57 Lindhagen T, Ekelund G, Leandoer L, Hildell J, Lindström C, Wenckert A. Crohn's disease in a defined population course and results of surgical treatment. Part II. Large bowel disease. Acta Chir Scand 1983; 149 (04) 415-421
- 58 Ambrose NS, Keighley MR, Alexander-Williams J, Allan RN. Clinical impact of colectomy and ileorectal anastomosis in the management of Crohn's disease. Gut 1984; 25 (03) 223-227
- 59 Jones PF, Keenan RA. The place of colectomy with ileo-rectal anastomosis in inflammatory bowel disease. Ann Chir Gynaecol 1986; 75 (02) 75-81
- 60 Steinberg DM, Allan RN, Cooke WT, Alexander-Williams J. The place of ileorectal anastomosis in Crohn's disease. Aust N Z J Surg 1976; 46 (01) 49-54
- 61 Goligher JC. Surgical treatment of Crohn's disease affecting mainly or entirely the large bowel. World J Surg 1988; 12 (02) 186-190
- 62 Sciaudone G, Pellino G, Riegler G, Selvaggi F. Infliximab in drug-naïve patients with failed ileorectal anastomosis for Crohn's disease: a new chance for sparing the rectum?. Eur Surg Res 2011; 46 (04) 163-168
- 63 McKenna NP, Bews KA, Habermann EB, Dozois EJ, Lightner AL, Mathis KL. What factors are associated with the eventual need for an ileostomy after total abdominal colectomy and ileosigmoid or ileorectal anastomosis for Crohn's colitis in the biologic era?. Dis Colon Rectum 2020; 63 (04) 504-513
- 64 Salice M, Rizzello F, Sgambato D. et al. Long term remission after ileorectal anastomosis in Crohn's colitis. Dig Liver Dis 2021; 53 (05) 592-597
- 65 Baelum JK, Qvist N, Ellebaek MB. Ileorectal anastomosis in patients with Crohn's disease. Postoperative complications and functional outcome – a systematic review. Colorectal Dis 2021; 23 (10) 2501-2514
- 66 Kariv Y, Remzi FH, Strong SA, Hammel JP, Preen M, Fazio VW. Ileal pouch rectal anastomosis: a viable alternative to permanent ileostomy in Crohn's proctocolitis patients. J Am Coll Surg 2009; 208 (03) 390-399
- 67 Braveman JM, Schoetz Jr DJ, Marcello PW. et al. The fate of the ileal pouch in patients developing Crohn's disease. Dis Colon Rectum 2004; 47 (10) 1613-1619
- 68 Hartley JE, Fazio VW, Remzi FH. et al. Analysis of the outcome of ileal pouch-anal anastomosis in patients with Crohn's disease. Dis Colon Rectum 2004; 47 (11) 1808-1815
- 69 Lightner AL, Pemberton JH, Loftus Jr EJ. Crohn's disease of the ileoanal pouch. Inflamm Bowel Dis 2016; 22 (06) 1502-1508
- 70 Tekkis PP, Heriot AG, Smith O, Smith JJ, Windsor AC, Nicholls RJ. Long-term outcomes of restorative proctocolectomy for Crohn's disease and indeterminate colitis. Colorectal Dis 2005; 7 (03) 218-223
- 71 Lee PY, Fazio VW, Church JM, Hull TL, Eu KW, Lavery IC. Vaginal fistula following restorative proctocolectomy. Dis Colon Rectum 1997; 40 (07) 752-759
- 72 Fazio VW, Kiran RP, Remzi FH. et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg 2013; 257 (04) 679-685
- 73 Li Y, Stocchi L, Mu X, Cherla D, Remzi FH. Long-term outcomes of sphincter-saving procedures for diffuse Crohn's disease of the large bowel. Dis Colon Rectum 2016; 59 (12) 1183-1190
- 74 Le Q, Melmed G, Dubinsky M. et al. Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's disease. Inflamm Bowel Dis 2013; 19 (01) 30-36
- 75 Panis Y, Poupard B, Nemeth J, Lavergne A, Hautefeuille P, Valleur P. Ileal pouch/anal anastomosis for Crohn's disease. Lancet 1996; 347 (9005): 854-857
- 76 Regimbeau JM, Panis Y, Pocard M. et al. Long-term results of ileal pouch-anal anastomosis for colorectal Crohn's disease. Dis Colon Rectum 2001; 44 (06) 769-778
- 77 Lightner AL, Jia X, Zaghiyan K, Fleshner PR. IPAA in known preoperative Crohn's disease: a systematic review. Dis Colon Rectum 2021; 64 (03) 355-364
- 78 Sacks GD, Dawes AJ, Ettner SL. et al. Surgeon perception of risk and benefit in the decision to operate. Ann Surg 2016; 264 (06) 896-903
- 79 Neary PM, Aiello AC, Stocchi L. et al. High-risk ileocolic anastomoses for Crohn's disease: when is diversion indicated?. J Crohn's Colitis 2019; 13 (07) 856-863
- 80 Yoon YS, Stocchi L, Holubar S. et al. When should we add a diverting loop ileostomy to lararoscopic ileocolic resection for primary Crohn's disease?. Surg Endosc 2021; 35 (06) 2543-2557
- 81 Myrelid P, Söderholm JD, Olaison G, Sjödahl R, Andersson P. Split stoma in resectional surgery of high-risk patients with ileocolonic Crohn's disease. Colorectal Dis 2012; 14 (02) 188-193
- 82 Bolckmans R, Singh S, Ratnatunga K. et al. Temporary faecal diversion in ileocolic resection for Crohn's disease: is there an impact on long-term surgical recurrence?. Colorectal Dis 2020; 22 (04) 430-438